Patents by Inventor Tsuneaki Asai

Tsuneaki Asai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8163546
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: April 24, 2012
    Assignee: Abbott Biotherapeutics Corp.
    Inventors: Yoshiko Akamatsu, Tsuneaki Asai, Naoya Tsurushita
  • Publication number: 20110008883
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Application
    Filed: March 26, 2010
    Publication date: January 13, 2011
    Applicants: FACET BIOTECH CORPORATION, PDL BIOPHARMA, INC.
    Inventors: YOSHIKO AKAMATSU, TSUNEAKI ASAI, NAOYA TSURUSHITA
  • Patent number: 7732195
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: June 8, 2010
    Assignee: Facet Biotech Corporation
    Inventors: Yoshiko Akamatsu, Tsuneaki Asai, Naoya Tsurushita
  • Publication number: 20090111126
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Application
    Filed: November 1, 2007
    Publication date: April 30, 2009
    Applicant: PDL BIOPHARMA, INC.
    Inventors: Yoshiko Akamatsu, Tsuneaki Asai, Naoya Tsurushita
  • Publication number: 20090019602
    Abstract: Disclosed is a complete plant MAP kinase cascade (e.g., MEKK1, MKK4/MKK5, and MPK3/MPK6) and WRKY22/WRKY29 transcription factors that function downstream of the flagellin receptor FLS2, a leucine-rich-repeat (LRR) receptor kinase. Activation of such a MAPK cascade confers resistance to both bacterial and fungal pathogens. Also disclosed are disease-resistant plants expressing one or more members of this MAP kinase signaling cascade. Such members include constitutively active MEKK1 (?MEKK1), MKK4 (MKK4a), and MKK5 (MKK5a) or wild-type WRKY29.
    Type: Application
    Filed: June 20, 2008
    Publication date: January 15, 2009
    Inventors: Jen Sheen, Frederick M. Ausubel, Tsuneaki Asai, Guillaume Tena
  • Publication number: 20050262584
    Abstract: Disclosed is a complete plant MAP kinase cascade (e.g., MEKK1, MKK4/MKK5, and MPK3/MPK6) and WRKY22/WRKY29 transcription factors that function downstream of the flagellin receptor FLS2, a leucine-rich-repeat (LRR) receptor kinase. Activation of such a MAPK cascade confers resistance to both bacterial and fungal pathogens. Also disclosed are disease-resistant plants expressing one or more members of this MAP kinase signaling cascade. Such members include constitutively active MEKK1 (?MEKK1), MKK4 (MKK4a), and MKK5 (MKK5a) or wild-type WRKY29.
    Type: Application
    Filed: September 12, 2003
    Publication date: November 24, 2005
    Inventors: Jen Sheen, Frederick Ausubel, Tsuneaki Asai, Guillaume Tena